Cardiovascular Market Research Reports & Industry Analysis
Variations in heart size and position within the chest may be related to age, body size, shape, weight, or pathologic conditions of the heart and other nearby structures.
There has been considerable study into the role of inflammation in heart disease. Researchers have found the first direct evidence that reducing inflammation in coronary arteries decreases the risk of heart attacks as much as reducing cholesterol levels. This finding offers a new approach to preventing heart disease. Two studies showed that inflammation of the arteries can be reduced by more aggressive use of statins. New drugs that target inflammation that are measured by a marker called Creactive rotein (CRP) could have a large impact on cardiovascular health as well as a large financial gain for companies developing these products.
Cardiovascular Industry Research & Market Reports
-
Global Acute Rehabilitation Market Size Study, by Phase Type (Phase I- Acute Phase, Phase II- Subacute Phase, Phase III- Intensive Outpatient Therapy, Phase IV- Independent Ongoing Conditioning), by Devices Product (Blood Pressure Monitor, Heart Rate Monitor, Rower, Seated & Upright Elliptical Trainer, Stabilization Ball, Stationary Bicycle, Treadmill), by Disease Type (Abnormal Heart Rhythms, Angina, Atrial Fibrillation, Cholesterol Management, Coronary Artery Bypass Surgery, Coronary or Peripheral Artery Disease, Diabetes, Heart Failure or Transplant, High Blood Pressure, Pulmonary Hypertension), by End User (Home Care, Hospitals & Clinics, Rehabilitation Centers, Specialty Centers), and Regional Forecasts 2022-2032
... Monitor, Rower, Seated & Upright Elliptical Trainer, Stabilization Ball, Stationary Bicycle, Treadmill), by Disease Type (Abnormal Heart Rhythms, Angina, Atrial Fibrillation, Cholesterol Management, Coronary Artery Bypass Surgery, Coronary or Peripheral Artery Disease, Diabetes, Heart Failure ... Read More
-
Global Diuretic Drugs Market 2024-2028
... market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the ... Read More
-
Global Decentralised Clinical Trials Market Size Study, by Study Design (Interventional, Observational, Expanded Access), by Indication (Oncology, Cardiovascular, Immunology, Respiratory, Others), by Component (Mobile Healthcare, Telemedicine, Wearable Devices, Web-based Technology, Others), by End-users (Pharmaceutical and Biopharmaceutical Companies, CROs, Others) and Regional Forecasts 2022-2032
... Biopharmaceutical Companies, CROs, Others) and Regional Forecasts 2022-2032 Global Decentralised Clinical Trials Market is valued at approximately USD 9.30 billion in 2023 and is anticipated to grow with a healthy growth rate of more than ... Read More
-
Global Statin Market 2024-2028
... holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the latest trends and ... Read More
-
Cardiovascular Drugs Industry Forecasts - China Focus
... manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far outpacing other economies in the world, China ... Read More
-
Cardiovascular Drugs Markets in China
... maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, ... Read More
-
Cardiovascular Drugs Companies in China
... the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far outpacing other economies in the world, ... Read More
-
Cholesterol Testing
... at a CAGR of 4.5% over the analysis period 2023-2030. Diagnostic Centers End-Use, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$11.6 Billion by the end ... Read More
-
Acute Heart Failure (AHF) Therapeutics
... is expected to reach US$2.9 Billion by 2030, growing at a CAGR of 21.3% over the analysis period 2023-2030. Cardiac Glycosides, one of the segments analyzed in the report, is expected to record a 21.8% ... Read More
-
Perfusion Systems
... at a CAGR of 4.3% over the analysis period 2023-2030. Cardiopulmonary Perfusion Systems, one of the segments analyzed in the report, is expected to record a 3.3% CAGR and reach US$671.0 Million by the end ... Read More
-
Atrial Fibrillation Devices
... by 2030, growing at a CAGR of 12.2% over the analysis period 2023-2030. EP Ablation Catheters, one of the segments analyzed in the report, is expected to record a 14.6% CAGR and reach US$4.8 Billion ... Read More
-
Cardiology IT Workflow Solutions
... reach US$1.8 Billion by 2030, growing at a CAGR of 8.0% over the analysis period 2023-2030. Cloud Deployment, one of the segments analyzed in the report, is expected to record a 9.0% CAGR and reach ... Read More
-
Cardiovascular Catheters
... at a CAGR of 6.5% over the analysis period 2023-2030. Cardiovascular Therapeutic Catheters, one of the segments analyzed in the report, is expected to record a 6.9% CAGR and reach US$25.4 Billion by the end ... Read More
-
Carotid Stents
... at a CAGR of 8.7% over the analysis period 2023-2030. Balloon Expandable Stents, one of the segments analyzed in the report, is expected to record a 8.2% CAGR and reach US$4.3 Billion by the end ... Read More
-
Acute Coronary Syndrome
... by 2030, growing at a CAGR of 10.5% over the analysis period 2023-2030. The U.S. Market is Estimated at US$2.3 Billion While China is Forecast to Grow at 16.4% CAGR The Acute Coronary Syndrome market ... Read More
-
Peripheral Arterial Disease (PAD) Therapeutics
... is expected to reach US$7.8 Billion by 2030, growing at a CAGR of 7.0% over the analysis period 2023-2030. Peripheral Stents, one of the segments analyzed in the report, is expected to record a 6.8% ... Read More
-
Cardiovascular Disease Monitoring and Diagnostic Devices
... the year 2023, is expected to reach US$3.6 Billion by 2030, growing at a CAGR of 4.6% over the analysis period 2023-2030. ECG Systems, one of the segments analyzed in the report, is expected to ... Read More
-
Anticoagulants
... of 9.1% over the analysis period 2023-2030. NOACs Drug Class, one of the segments analyzed in the report, is expected to record a 10.8% CAGR and reach US$33.4 Billion by the end of the analysis ... Read More
-
Cardiovascular Drugs
... at a CAGR of 3.5% over the analysis period 2023-2030. Anticoagulants, one of the segments analyzed in the report, is expected to record a 4.0% CAGR and reach US$57.7 Billion by the end of the ... Read More
-
Dyslipidemia - Global Clinical Trials Review, 2024
... report provides top line data relating to the clinical trials on Dyslipidemia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of ... Read More
-
Minimally Invasive Surgical Instruments Market by Product (Handheld, Inflation Devices, Surgical Scopes), Type of Surgery (Cardiothoracic, Gastrointestional, Bariatric, Orthopedic, Urological), Technology (Non-robotic, Robotic) - Global Forecast to 2029
... projected to reach USD 49.9 Billion by 2029 from USD 31.7 Billion in 2024, at a CAGR of 9.5% during the forecast period. Market expansion is propelled by factors such as the growing utilization of ... Read More
-
Germany Rna Interference (Rnai) Drug Delivery Market Forecast 2024-2032
... to reach a revenue of $23164.24 million by 2032. MARKET INSIGHTS The Germany RNA interference (RNAi) drug delivery market is experiencing significant growth, driven by the increasing demand for RNAi therapeutics. This surge in demand ... Read More
-
2024 Global: Myocardial Fibrosis Market - Innovative Markets Forecast (2030) report
... 2019 through 2030. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2019 to 2030 using regression ... Read More
-
Global Atherosclerosis Therapeutics Market 2024-2028
... market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the ... Read More
-
Cardiac Biomarkers Market, By Product Type (Myocardial Muscle Creatine Kinase, Myoglobin, Troponins, Brain Natriuretic Peptide or NT-proBNP, Ischemia-modified Albumin, and Others), By Application (Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome, Atherosclerosis, and Others), By Location of Testing (Laboratory Testing and Point of Care Testing), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... Location of Testing (Laboratory Testing and Point of Care Testing), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) Cardiac biomarkers refer to proteins that are present in blood when the ... Read More
Research Assistance
